000 | 01531 a2200433 4500 | ||
---|---|---|---|
005 | 20250512002835.0 | ||
264 | 0 | _c19891012 | |
008 | 198910s 0 0 eng d | ||
022 | _a0022-2623 | ||
024 | 7 |
_a10.1021/jm00129a009 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBotros, S | |
245 | 0 | 0 |
_aOpioid agonist and antagonist activities of peripherally selective derivatives of naltrexamine and oxymorphamine. _h[electronic resource] |
260 |
_bJournal of medicinal chemistry _cSep 1989 |
||
300 |
_a2068-71 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aChemical Phenomena |
650 | 0 | 4 | _aChemistry |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 | _aGuinea Pigs |
650 | 0 | 4 |
_aHydromorphone _xanalogs & derivatives |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMuscle, Smooth _xdrug effects |
650 | 0 | 4 |
_aNaltrexone _xadministration & dosage |
650 | 0 | 4 |
_aNarcotic Antagonists _xadministration & dosage |
650 | 0 | 4 |
_aOxymorphone _xadministration & dosage |
650 | 0 | 4 |
_aPain _xdrug therapy |
650 | 0 | 4 | _aStructure-Activity Relationship |
700 | 1 | _aLipkowski, A W | |
700 | 1 | _aLarson, D L | |
700 | 1 | _aStark, P A | |
700 | 1 | _aTakemori, A E | |
700 | 1 | _aPortoghese, P S | |
773 | 0 |
_tJournal of medicinal chemistry _gvol. 32 _gno. 9 _gp. 2068-71 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00129a009 _zAvailable from publisher's website |
999 |
_c2481634 _d2481634 |